Application no. and date | 18164175.4 (espacenet) (Federated) (European Patent Register), 20111027 | Patent/reg. no. and date | DK/EP 3412687, 20200318 | Publication date | 20181212 | Priority no. and date | US 40710710 P, 20101027 | EP pub. no. and date |
EP 3412687 20181212 | Effective date | | Applicant/owner | Amgen Research (Munich) GmbH, Staffelseestrasse 2
81477 München, DE | Applicant ref. no. | 1535236 | Inventor | ZUGMAIER, Gerhard, c/o Amgen Research (Munich) GmbH Staffelseestrasse 2
81477 Munich, DE, NAGORSEN, Dirk, 65 Brookside Pl
Thousand Oaks, CA 91320, US, SCHEELE, Juergen, Hügelheimer Weg 11
79426 Buggingen, DE | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | Opponent | | IPC Class | A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) , C07K 16/46 (2006.01) | Title | FREMGANGSMÅDER TIL BEHANDLING AF DLBCL | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | Ophævet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|